176 related articles for article (PubMed ID: 28630093)
1. Dendritic Cell Sensing of Hydrophobic Di- and Triacylated Lipopeptides Self-Assembled within Synthetic Virus-like Particles.
Sharma R; Ghasparian A; Robinson JA; McCullough KC
J Immunol; 2017 Jul; 199(2):734-749. PubMed ID: 28630093
[TBL] [Abstract][Full Text] [Related]
2. Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis.
Sharma R; Ghasparian A; Robinson JA; McCullough KC
PLoS One; 2012; 7(8):e43248. PubMed ID: 22905240
[TBL] [Abstract][Full Text] [Related]
3. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Kang JY; Nan X; Jin MS; Youn SJ; Ryu YH; Mah S; Han SH; Lee H; Paik SG; Lee JO
Immunity; 2009 Dec; 31(6):873-84. PubMed ID: 19931471
[TBL] [Abstract][Full Text] [Related]
4. Lipopeptides are signaled by Toll-like receptor 1, 2 and 6 in endolysosomes.
Motoi Y; Shibata T; Takahashi K; Kanno A; Murakami Y; Li X; Kasahara T; Miyake K
Int Immunol; 2014 Oct; 26(10):563-73. PubMed ID: 24860120
[TBL] [Abstract][Full Text] [Related]
5. Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune Response.
Wijayadikusumah AR; Zeng W; McQuilten HA; Wong CY; Jackson DC; Chua BY
Mol Pharm; 2019 May; 16(5):2037-2047. PubMed ID: 30924661
[TBL] [Abstract][Full Text] [Related]
6. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells.
Nakao Y; Funami K; Kikkawa S; Taniguchi M; Nishiguchi M; Fukumori Y; Seya T; Matsumoto M
J Immunol; 2005 Feb; 174(3):1566-73. PubMed ID: 15661917
[TBL] [Abstract][Full Text] [Related]
7. Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.
Akazawa T; Ohashi T; Wijewardana V; Sugiura K; Inoue N
Cancer Sci; 2018 May; 109(5):1319-1329. PubMed ID: 29575556
[TBL] [Abstract][Full Text] [Related]
8. PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8
Sekiya T; Yamagishi J; Gray JHV; Whitney PG; Martinelli A; Zeng W; Wong CY; Sugimoto C; Jackson DC; Chua BY
Biomaterials; 2017 Aug; 137():61-72. PubMed ID: 28544973
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses.
Chua BY; Johnson D; Tan A; Earnest-Silveira L; Sekiya T; Chin R; Torresi J; Jackson DC
PLoS One; 2012; 7(10):e47492. PubMed ID: 23091628
[TBL] [Abstract][Full Text] [Related]
10. Development of a dendritic cell-targeting lipopeptide as an immunoadjuvant that inhibits tumor growth without inducing local inflammation.
Akazawa T; Ohashi T; Nakajima H; Nishizawa Y; Kodama K; Sugiura K; Inaba T; Inoue N
Int J Cancer; 2014 Dec; 135(12):2847-56. PubMed ID: 24789268
[TBL] [Abstract][Full Text] [Related]
11. Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6.
Turner ML; Cronin JG; Healey GD; Sheldon IM
Endocrinology; 2014 Apr; 155(4):1453-65. PubMed ID: 24437488
[TBL] [Abstract][Full Text] [Related]
12. TLR1- and TLR6-independent recognition of bacterial lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
J Biol Chem; 2006 Apr; 281(14):9049-57. PubMed ID: 16455646
[TBL] [Abstract][Full Text] [Related]
13. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.
Nakata T; Yasuda M; Fujita M; Kataoka H; Kiura K; Sano H; Shibata K
Cell Microbiol; 2006 Dec; 8(12):1899-909. PubMed ID: 16848791
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
[TBL] [Abstract][Full Text] [Related]
15. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.
Ranoa DRE; Kelley SL; Tapping RI
J Biol Chem; 2013 Apr; 288(14):9729-9741. PubMed ID: 23430250
[TBL] [Abstract][Full Text] [Related]
16. Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.
Shepardson KM; Schwarz B; Larson K; Morton RV; Avera J; McCoy K; Caffrey A; Harmsen A; Douglas T; Rynda-Apple A
mBio; 2017 Nov; 8(6):. PubMed ID: 29138299
[TBL] [Abstract][Full Text] [Related]
17. Recognition of lipopeptides by Toll-like receptors.
Takeda K; Takeuchi O; Akira S
J Endotoxin Res; 2002; 8(6):459-63. PubMed ID: 12697090
[TBL] [Abstract][Full Text] [Related]
18. N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2.
Willems MM; Zom GG; Khan S; Meeuwenoord N; Melief CJ; van der Stelt M; Overkleeft HS; Codée JD; van der Marel GA; Ossendorp F; Filippov DV
J Med Chem; 2014 Aug; 57(15):6873-8. PubMed ID: 25019313
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity.
Pavot V; Rochereau N; Rességuier J; Gutjahr A; Genin C; Tiraby G; Perouzel E; Lioux T; Vernejoul F; Verrier B; Paul S
J Immunol; 2014 Dec; 193(12):5781-5. PubMed ID: 25392526
[TBL] [Abstract][Full Text] [Related]
20. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
